Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-01-08 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHATEAULIN (29150), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE POTIER : revenue, balance sheet and financial ratios
PHARMACIE POTIER is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHATEAULIN (29150),
this company of category PME
shows in 2022 a revenue of 2.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE POTIER (SIREN 790330237)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 824 396 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
207 192 €
248 868 €
221 213 €
212 142 €
221 428 €
-129 354 €
182 800 €
231 631 €
EBITDA
N/C
372 875 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
8.8%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE POTIER generates positive net income of 207 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 232 k€ -> 207 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
207 192 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 56%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
55.781%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.855%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
235.335
168.975
180.389
126.757
109.116
77.21
64.51
55.781
Financial autonomy
26.749
33.136
31.532
38.777
41.777
50.044
54.102
56.855
Repayment capacity
None
None
None
None
None
None
3.529
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
10.198%
None%
Sector positioning
Debt ratio
55.782023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good
In 2023, the debt ratio of PHARMACIE POTIER (55.78) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
56.85%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good
In 2023, the financial autonomy of PHARMACIE POTIER (56.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
3.53 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE POTIER (3.53) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 162.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
162.359
Liquidity indicators evolution PHARMACIE POTIER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
112.638
102.807
92.935
114.789
157.961
163.535
171.777
162.359
Interest coverage
None
None
None
None
None
None
2.606
None
Sector positioning
Liquidity ratio
162.362023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average
In 2023, the liquidity ratio of PHARMACIE POTIER (162.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.61x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE POTIER (2.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE POTIER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
215 586 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
33
0
Customer payment term (days)
0
0
0
0
0
0
0
0
Supplier payment term (days)
0
0
0
0
0
0
49
0
Positioning of PHARMACIE POTIER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE POTIER is estimated at
2 444 757 €
(range 1 486 773€ - 3 436 779€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1486k€2444k€3436k€
2 444 757 €Range: 1 486 773€ - 3 436 779€
NAF 5 année 2023
Valuation method used
Net Income Multiple
207 192 €
×
11.8x
=2 444 757 €
Range: 1 486 774€ - 3 436 780€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE POTIER with other companies in the same sector:
The revenue of PHARMACIE POTIER in 2022 is 2.8 M€.
Is PHARMACIE POTIER profitable?
Yes, PHARMACIE POTIER generated a net profit of 207 k€ in 2023.
Where is the headquarters of PHARMACIE POTIER ?
The headquarters of PHARMACIE POTIER is located in CHATEAULIN (29150), in the department Finistere.
Where to find the tax return of PHARMACIE POTIER ?
The tax return of PHARMACIE POTIER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE POTIER operate?
PHARMACIE POTIER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart